Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors

International Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 747-754

  Ferrandina, Gabriella ^a   Almadori, Giovanni ^a   Maggiano, Nicola ^a   Lanza, Paola ^a   Ferlini, Cristiano ^a   Cattani, Paola ^a   Piantelli, Mauro ^b   Scambia, Giovanni ^a   Ranelletti, Franco O ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; BROXURIDINE; DEXAMETHASONE; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; IPRIFLAVONE; PROGESTERONE; QUERCETIN; TAMOXIFEN;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL CYCLE; COLONY FORMING CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CANCER; PRIORITY JOURNAL; RECEPTOR AFFINITY;

APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMANS; ISOFLAVONES; KINETICS; LARYNGEAL NEOPLASMS; QUERCETIN; RECEPTORS, ESTROGEN; TAMOXIFEN; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0031874309     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980831)77:5<747::AID-IJC14>3.0.CO;2-Z     Document Type: Article

References (23)

1. AVILA, M.A., VELASCO, J.A., CANSADO, J. and NOTARIO, V., Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res., 54, 2424-2428 (1994)
2. CARBONE, A., SERRA, F.G., FERRANDINA, G., SCAMBIA, G., TERRIBILE, D., BELLANTONE, R. and RANELLETTI, F.O., Methyl-p-hydroxyphenyllactate esterase activity in breast cancer: a potentially new prognostic factor in short term follow up. Cancer Res., 57, 5406-5409 (1997).
3. CATTARUZZA, M.S., MAISONNEUVE, P. and BOYLE, P., Epidemiology of laryngeal cancer. Oral Oncol. Europ. J. Cancer, 32, 293-305 (1996)
4. DI STEFANO, M., SCAMBIA, G., FERLINI, C., GAGGINI, C., DE VINCENZO, R., RIVA, A., BOMBARDELLI, E., FATTOROSSI, A., BENEDETTI PANICI, P. and MANCUSO, S., Antiproliferative activity of a new class of taxanes (14b-hydroxy-10-deacetylbaccatin III derivatives) on MDR positive human cancer cells. Int. J. Cancer, 72, 844-850 (1997).
5. FERRANDINA, G., RANELLETTI, F.O., SCAMBIA, G., BENEDETTI PANICI, P., D'AGOSTINO, G., PIANTELLI, M., ISOLA, G. and MANCUSO, S., Interaction of tamoxifen with cytosolic and nuclear Type II estrogen binding sites (Type II EBS). Cancer Lett., 96, 123-131 (1995)
6. FERRANDINA, G., SCAMBIA, G., BENEDETTI PANICI, P., RANELLETTI, F.O., DE VINCENZO, R., PIANTELLI, M., DISTEFANO, M., CAPELLI, A. and MANCUSO, S., Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor. Gynecol. Oncol., 49, 67-72 (1993)
7. GAVRIELL Y., SHERMAN, Y. and BEN-JASSON, S.A., Identification of programmed cell death in situ via specific labeling DNA fragmentation. J. Cell Biol., 119, 493-501 (1992)
8. KNABBE, C., LIPPMAN, M.E. and WAKEFIELD, L.M., Evidence that transforming growth factor beta is a hormonally regulated growth factor in human breast cancer cells. Cell. 48, 417-428 (1987)
9. LOPES, F., VALE, G.P. and CARVALHO, A.P., Ca2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res., 50, 2753-2758, (1990).
10. MARKAVERICH, B.M., GREGORY, R.R., ALEJANDRO, M.A., CLARK, J.H., JOHNSON, G.A. and MIDDLEDITCH, B.S., Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear Type II EBS. J. biol. Chem., 263, 7203-7210 (1988).
11. MAURIZI, M., FERRANDINA, G., ALMADORI, G., SCAMBIA, G., CADONI, G., D'AGOSTINO, G., SERRA, F.G., PIANTELLI, M., MANCUSO, S. and RANELLETTI, F.O., Prognostic significance of methyl-hydrohyphenyllactate esterase-activity in laryngeal squamous cell carcinomas. Brit. J. Cancer, (1998) (In press).
12. O'BRIAN, CA., LISKAMP, R.M., SALOMON, D.H. and WEINSTEIN, B., Inhibition of protein kinase C by tamoxifen. Cancer Res., 45, 2463-2465 (1985).
13. OSMOLSKI, A. and KUS, J.J., Clinical course of laryngeal cancer in relation to sex. Otolaryngol. Pol., 46, 117-126 (1992).
14. PIANTELLI, M., MAGGIANO, N., RICCI, R., LAROCCA, L.M., CAPELLI, A., SCAMBIA, G., ISOLA, G. and NATALI, P., Type II estrogen binding sites in human melanoma and growth-inhibitory effect of tamoxifen and quercetin. J. invest. Dermatol., 105, 248-253 (1995).
15. RANELLETTI, F.O., RICCI, R., LAROCCA, L.M., MAGGIANO, N., CAPELLI, A., SCAMBIA, G., BENEDETTI PANICI, P., MANCUSO, S., RUMI, C. and PIANTELLI, M., Growth-inhibitory effect of quercetin and presence of Type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer, 50, 486-492 (1992).
16. RANELLETTI, F.O., SCAMBIA, G., BENEDETTI PANICI, P., PIANTELLI, M., FERRANDINA, G., D'AGOSTINO, G., DE VINCENZO, R., RINELLI, A., ISOLA, G. and MANCUSO, S., Expression of methyl-p-hydroxyphenyllactate esterase activity and Type II estrogen binding sites (Type II EBS) in ovarian cancer: correlation with biological and clinico-pathological parameters. Int. J. Cancer, 62, 536-541 (1995).
17. REINER, Z., CYRTILA, D. and PETRIC, V., Cytoplasmic receptors in cancer of the larynx. Arch. Otolaryngol., 245, 47-49 (1988).
18. ROBBINS, K.T., VU, T.P., DIAZ, A. and VARKI, N.M., Growth effects of tamoxifen and estradiol on laryngeal carcinoma cell lines. Arch. Otolaryngol. Head Neck Surg., 120, 1261-1266 (1994).
19. SCAMBIA, G., BENEDETTI PANICI, P., BATTAGLIA, F., FERRANDINA, G., ALMADORI, G., PALUDETTI, G., MAURIZI, M. and MANCUSO, S., Receptors for epidermal growth factor, and steroid hormones in primary laryngeal tumors. Cancer, 67, 1347-1351 (1991a)
20. SCAMBIA, G., RANELLETTI, F.O., BENEDETTI PANICI, P., PIANTELLI, M., BONANNO, G., DE VINCENZO, R., FERRANDINA, G., PIERELLI, L., CAPELLI, A. and MANCUSO, S., Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing Type II estrogen-binding sites. Cancer Chem. Pharm., 28, 255-258 (1991b).
21. SCAMBIA, G., RANELLETTI, F.O., BENEDETTI PANICI, P., PIANTELLI, M., DE VINCENZO, R., BONANNO, G., FERRANDINA, G., ISOLA, G. and MANCUSO, S., Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours. Europ. J. Cancer, 28, 1885-1889 (1992).
22. SYNE, J.S., MARKAVERICH, B.M., CLARK, J.H. and PANKO, W.B., Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple binding sites. Cancer Res., 42, 4449-4456 (1982).
23. ZHAO, X., XIAO, X. and LIU, J., Effects of sexual hormones on proliferation of laryngeal carcinoma cell line Hep2 in vitro. Chung Hua Erh Pi Yen Hon Ko Tsa Chih, 29, 149-151, (1994).